Homer's syndrome occurred in a young woman as a complication of the treatment of a traumatic pneumothorax with an intercostal drain. The nerve damage probably occurred when the lung had fully re-expanded, pressing the tip of the intercostal drain, lying at the apex of the pleural cavity, on to the sympathetic chain.
Summary Patients undergoing biliary surgery received either 750 mg cefuroxime i.m. with the premedication and then 8 hourly for 3 days ((group A) or 1.5 g cefuroxime i.v. at the time of induction of anaesthesia (group B) or not treatment (group C). Wound infections occurred in 3 out of 35 patients in group A, 1 out of 40 patients in group B and 11 out of 39 patients in group C (group B significantly different than group C, P less than 0.05). Eight patients (23%) in group C had chest complications. Cefuroxime was effective in the reduction of wound sepsis following biliary surgery and 1.5 g i.v. administered during induction of anaesthesia is the dosage of choice. The incidence of chest infection tended to be lower in patients receiving cefuroxime but many more patients would have to be studied for a conclusive result.
Poster sessions A152Thorax 2012;67(Suppl 2):A1-A204 years] were intended to undergo lobectomy via Single-Port technique. Data in Median (Range). Results Thoraco score was 1.57 (0.1-11.8)and FEV 1 was 74 (34-157) % predicted. Thirteen operations were right-sided (5 upper, 2 middle and 6 lower lobectomies), and eleven left-sided (6 upper and 5 lower).Operations lasted 127 (65-194)minutes. One intercostal drain was used in all cases, and it was removed at 3 (1-9)days. Patients were discharged home at 3 (range 1-21) days. There was one postoperative death in our experience, a patient who was ready for discharge 3 days after surgery when he suffered a dense middle cerebral artery stroke that led to his death by contralateral pneumonia 20 days later. One case was converted to thoracotomy due to bleeding and another case a retractor was used in the incision to enable safe suture of a branch of the pulmonary artery after partial failure of the stapler.In 10 of the 24 patients the patients started oral analgesia on the day of surgery without the use of epidurals or paravertebral catheters. Conclusion Single-Port VATS lobectomy is feasible and safe. It is becoming our approach of choice for early stage lung cancer due to its low incidence of complications and the very fast recovery with some patients going home as early as the day after surgery. This technique will make the case for surgery against newest techniques of radiotherapy for lung cancer. The NHS Information Centre, Leeds, UK Introduction Surgical resection is the best chance of cure for most patients with non-small cell lung cancer (NSCLC), for whom 5-year survival is otherwise poor. Selection of patients for surgery should include an estimation of the likely post-operative mortality risk but the tool often used in UK practise is a predictive score that was developed using a French database of thoracic surgical procedures, not specific to lung cancer. Methods We used data from the National Lung Cancer Audit linked with Hospital Episode Statistics to estimate the influence of pre-operative patient and tumour factors, and the type of procedure on the odds of death at 30 and 90 days after potentially curative surgery for NSCLC. We used logistic regression to determine which factors were associated with early post-operative mortality and then calculated the percentage of patients who died within 90 days of surgery, stratified by the strongest predictors of early post-operative mortality. Results We identified 12,096 patients who had potentially curative surgery for NSCLC in England between January 2004 and March 2010. Three per cent (n=387) and 6% (n=792) of patients died within 30 and 90 days respectively. Of the 12 clinical and sociodemographic factors assessed, age and type of procedure were consistently the most important predictors of early post-operative mortality: Odds ratio (OR) for death at 30 days for pneumonectomy compared with lobectomy 3.03, 95% confidence interval (CI) 2.32-3.94; and for each year increase in age OR 1.06, 95% CI 1.04-1.07. Performance...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.